# Southern Eye Bank – FDA Inspection, Apr 13, 2017

Source: https://www.keypedia.com/records/fda_inspections/southern-eye-bank/a6719193-a12d-41a8-935e-c7a8294229fb
Source feed: FDA_Inspections

> FDA inspection 1010185 of Southern Eye Bank, April 13, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1010185
- Company Name: Southern Eye Bank
- Inspection Date: 2017-04-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1307916 - 2026-03-06
- FDA Inspection 1208214 - 2023-05-25
- FDA Inspection 1095564 - 2019-04-08
- FDA Inspection 863714 - 2014-01-16
- FDA Inspection 678735 - 2010-08-25

## Related Officers

- [Company Rep](https://www.keypedia.com/people/barbara-d-wright/c824bcb9-76fb-4e83-86d0-013a9584c137)

Company: https://www.keypedia.com/companies/southern-eye-bank/65f21516-2ea5-4112-b655-a67b0ad659ba

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d